Form 4: Invivyd Director Marc Elia Awarded Stock Option

Marc Elia, a director of Invivyd, Inc., was granted a stock option for 50,000 shares, vesting in full by May 21, 2025, or the date of the 2025 Annual Meeting of Stockholders.

Summary

• On May 21, 2024, Marc Elia, a director of Invivyd, Inc., was granted a stock option to purchase 50,000 shares of common stock at an exercise price of $2.21 per share.
• The option vests in full upon the earlier of May 21, 2025, or the date of the Issuer's 2025 Annual Meeting of Stockholders, contingent upon continuous service.
• The grant is deemed to be held by Marc Elia for the benefit of M28 Capital Management LP and the funds it manages.
• M28 Capital Management LP may be considered a director by deputization due to Marc Elia's board service and indirect control over M28 Capital Management.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a standard executive compensation practice. It's neither overwhelmingly positive nor negative.

Positives

• The granting of stock options to directors can align their interests with those of shareholders, incentivizing them to work towards increasing the company's value.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock option.

Industry Context

This is a standard practice for incentivizing board members in publicly traded companies, particularly in the biotechnology sector where long-term growth is a key focus.

Comparison to Industry Standards

• Stock option grants are a common form of compensation for directors in publicly traded companies, especially in the biotech industry.
• Companies like Moderna and BioNTech also use stock options to incentivize their board members and align their interests with shareholders.
• The vesting schedule and exercise price are typical for such grants, aiming to reward long-term commitment and performance.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the director to work towards increasing shareholder value.
• Employees may see this as a sign of confidence in the company's future.

Key Dates